01-134 IMMUNSYSTEM AB Address:- Dag Hammarskjoelds Vaeg 26, 751 83 Uppsala, Sweden Webpage:- www.immunsystem.com E-mail:- info@immunsystem.se Phone:- +46 (18) 53 89 09--------- Fax: +46 (18) 53 89 97 Product Specification Sheet Description: Product No.: Lot No.: Antigen: p Host Animal: Titer: Form: Storage: Performance: ANTI HIRUDIN 01-134 - Recombinant hirudin (Refludan (...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
Approved Biotechnology Drugs, 2002 - Attention deficit hyperactivity disorder - Nov 2001 Follistim™ (follitropin beta) - Organon (unit of Akzo Nobel) - Recombinant follicle-stimulating hormone for treatment of infertility; induction of spermatogenesis in men with primary and secondary hypo-gonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure - Sep 1997 Feb...
http://www.easy.no/affitech/pdf/das1.pdf page 1
duplicates:http://www.iscpubs.com/articles/abl/b0002das.pdf
Prescription and OTC Drug Product List 11/2001 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET; ORAL PERCOCET -A- + ENDO PHARMS 325MG;7.5MG N40434 001 NOV 23, 2001 NOV NEWA -A- + 325MG;10MG N40434 002 NOV 23, 2001 NOV NEWA ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE -A- AB ANABOLIC 325MG;50MG;40MG;30MG...
http://www.iscpubs.com/articles/acl/c0106das.pdf Although some of these products would require a few m o re years of cli nical study before they can be assessed for their marketability, if successful, a market explosion with a potential of dozens of appro v e d d rugs per year, beginning in 2001, could be expected Table 1 continued Year Product name/ approved biochemical identity Company Indications 1996 Humatrope/ HGH Eli Lilly...
author: Grace Lee
http://www.iscpubs.com/articles/abl/b0002das.pdf DAS Table 1 List of approved protein therapeutics Year Product name/ approved biochemical identity Company Indications 1982 Humalog/ human insulin Eli Lilly Diabetes Novolin/ human insulin Novo Nordisk Diabetes 1985 Protropin/ HGH Genentech HGHdeficiency 1986 Roferon- A/ interferon alpha- 2a Hoffmann- La Roche Hairy cell leukemia, AIDS- related Kaposi's sarcoma (1988),* chronic...
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Introduction: Bleeding and Clotting Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Btech News - Benefits of Angiomax and Refludan - - - - BioNews BioWeb Companies Products BioReports - - - - - - Btech News - Benefits of Angiomax and Refludan Bivalent direct thrombin inhibitors (The Medicines Company's [NASDAQ: MDCO] Angiomax [bivalirudin] and Aventis's (NYSE: AVE) Refludan [lepirudin]) demonstrated important clinical advantages over univalent direct thrombin inhibitors (GlaxoSmithKline [NYSE:...
biovista.com : biotechnology companies Box 9627 Post Code: Kansas City, MO 64134-0627 Tel: 888-242-9321 Fax: Web Site: www.hmri.com People: Products: Allegra® (fexofenadine HCl) Allegra-D™ (fexofenadine), Altace® (ramipril), Amaryl® (glimepiride tablets), Anzemet® Tablets (dolasetron mesylate), Anzemet® Injection (dolasetron mesylate injection), Carafate® (sucralfate), Cardizem® CD ...
author: genesis studios, http://www.genesis-studios.cc
Cardiovascular and Renal Drugs Advisory Committee Meetings FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER < a href="http://www.fda.gov/cder/regulatory/default.htm" onMouseOut="MM_startTimeout();" onMouseOver="MM_showMenu(window.mm_menu_0718112003_0,0,33,null,'Sm_Button_Regulatory_Off');"> - Search - Cardiovascular and Renal Drugs Advisory Committee Meetings List of Tentative Meeting Dates for All CDER...
Therapeutic Product Portfolio - About Berlex | Contact Us | Feedback | Site Map | Search - Patients Healthcare Professionals Clinical Trials Home - Products Therapeutic Product Portfolio Cardiovascular Berlex is aggressively seeking new approaches in cardiovascular medicine both through basic research and acquisitions
Products Aphabetical List - About Berlex | Contact Us | Feedback | Site Map | Search - Patients Healthcare Professionals Clinical Trials Home - Products Alphabetical Listing of Products Select a product name for more information ACUTECT® kit for the preparation of technetium to 99m depreotide injection BETAPACE® sotalol HCI BETAPACE AF® sotalol HCI BETASERON® interferon beta-1b CAMPATH®...
Select Berlex Milestones - About Berlex | Contact Us | Feedback | Site Map | Search - Patients Healthcare Professionals Clinical Trials Home - About Selected Berlex Milestones - 1979 Enters the U.S
Feedback Check which products you use (check all that apply) * ACUTECT® (kit for the preparation of technetium tc 99m apcitide injection) BETASERON® (interferon beta-1b) BETAPACE® (sotalol HCI) BETAPACE AF™ (sotalol HCI) CAMPATH® (afemtuzumab) CLIMARA® (estradiol transdermal system) FERIDEX I.V.® (ferumoxides injectable solution) FINEVIN™ (azelaic acid cream,...
20807_Refludan Food and Drug Administration • Center for Drug Evaluation and Research Review Package Search Refludan [Lepirudin (rDNA)] Injection Company:--Hoechst Marion Roussel Application No.:--20-807 Approval Date:-3/6/1998 Approval Letter(s) - Approvable Letter - Medical Review(s) Part 1 - Part 2 -- Chemistry Review(s) - Pharmacology Review(s)- Part 1 - Part 2 - Part 3 - Part...
author: USERNAME
http://www.accumetrics.com/uploads/p2Y12polymorph.pdf Adenosine Diphosphate± Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects Pierre Fontana, MD; Annabelle Dupont, MSc; Sophie Gandrille, PhD; Christilla Bachelot- Loza, PhD; Jean- Luc Reny, MD, PhD; Martine Aiach, PhD; Pascale Gaussem, PhD BackgroundTH The adenosine diphosphate (ADP) receptor P2Y12 plays a pivotal role in platelet...
http://www.accumetrics.com/uploads/p2Y12polymorph.pdf page 2
BIO Editors &Reporters 03LIVE page 65
author: Elinor
Conversions UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
author: Bowne
Conversions page 6
author: Bowne
duplicates:http://www.tbc.com/content/2000ar10k.pdf
Medicinal Products with a Community Marketing authorisation - Status October 2002 page 5 List Medicinal Products granted a Community Marketing Authorisation under the Centralised Procedure Product a) Brandname b) INN c) Part A/ B Company a) Name b) Origin Therapeutic Area a) ATC b) Indication Presentation a) Form b) Strengths c) Number of Presentations EMEA/ CPMP a) Validation b) Opinion ...
author: EMEA
subject: List
Refludan - Fatal anaphylactic reactions EMEA Public statement The European Agency for the Evaluation of Medicinal Products Post- authorisation evaluation of medicines for human use Public 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 68 E- mail: mail@ emea. eu. int http:// www. emea. eu. int/ London, October ...
author: CPMP
subject: EMEA Public statement
